Purpose To investigate the progression of cataract after a high dose (25 mg) intravitreal
triamcinolone acetonide injection in patients with macular oedema secondary to diabetes …

Purpose To report the clinical outcome of patients undergoing cataract surgery after one or
repeated intravitreal injections of triamcinolone acetonide as treatment of intraocular …

Purpose: To describe the 3‐year risk of cataract after intravitreal triamcinolone (IVTA)
injections for diabetic macular oedema and the outcomes of cataract surgery. Methods …

Purpose To evaluate the frequency of cataract surgery after intravitreal injection of high-
dosage triamcinolone acetonide in elderly patients. Methods This clinical interventional case …

Purpose To investigate 2-year results of intravitreal triamcinolone acetonide injection for the
treatment of diffuse diabetic macular edema unresponsive to previous laser …

Purpose To evaluate the effect of intravitreal triamcinolone acetonide (IVT) reinjection on
clinical and optical coherence tomographic features in refractory diabetic macular edema …

PURPOSE: To evaluate the early effects of intravitreal triamcinolone acetonide (TA) on
cystoid macular edema associated with retinal vein occlusion and diabetic retinopathy …

Purpose To report on the follow-up of patients who received an intravitreal high-dosage
injection of triamcinolone acetonide (IVTA) as treatment of diffuse diabetic macular edema …

Purpose To evaluate the effectiveness of intravitreal triamcinolone injection on the course of
diabetic macular edema. Methods Forty-eight eyes of 48 diabetic patients were treated with …

Objective To evaluate which factors influence maximum gain in best-corrected visual acuity
after intravitreal injection of triamcinolone acetonide as treatment for diffuse diabetic macular …